Irvine Scientific, a member of JX Group, is a worldwide leader in the innovation and manufacture of cell culture media, reagents, and medical devices for researchers and clinicians. The company provides unrivalled service and quality to scientists working in cell therapy and regenerative medicine, assisted reproductive technology and cytogenetics, and industrial cell culture for the large-scale production of biotherapeutics and vaccines. Irvine Scientific adheres to both ISO and FDA regulations and operates dual cGMP manufacturing facilities in California, USA and Tokyo, Japan. The company’s consultative philosophy combined with expertise in cell culture and compliance provides customers with unique capabilities and support. For over 40 years, Irvine Scientific has remained uniquely flexible and focused on media while becoming a strategic global leader in media products and services.
Hematopoietic stem and progenitor cells (HSPCs) hold tremendous therapeutic potential for use in cell therapies to treat blood cancers and other blood diseases including sickle cell anemia and immune related disorders. HSPCs most frequently are ... Continued
PRIME-XV® T Cell CDM – First Commercially Available Chemically-defined, Animal-component-free Medium for T Cell Culture
Gene therapies and immunotherapies hold tremendous promise to treat diseases in a completely novel way. As increasing numbers of these therapies move from research and proof of concept to clinical trials, the manufacturing requirements will ... Continued
The BalanCD® HEK293 system is chemically-defined, animal component-free, and designed to support growth and transfection of HEK293 cell lines in suspension cultures, and supports a range of applications including production of viral vectors and recombinant protein production....Continued
Neural progenitor cells (NPCs) derived from primary tissue and pluripotent stem cells have proven to be a powerful tool for gaining insight into the human nervous system as well as associated disease states. Impaired neurons ... Continued
Recently, Irvine Scientific launched their BalanCD® Transfectory™ CHO system of medium and supplements for transient transfection in CHO cells. The system provides a scalable platform approach to transient transfection CHO with milligram to gram-scale yields of recombinant proteins....Continued
In order to meet pressing product production timelines and achieve top performance, high cell growth and titers must be reached. (Figure 1) According to data presented by Irvine Scientific, Feed 4 was compared with various feed media currently on the market. Feed 4 outperformed all the other feed media....Continued